Skip to content

Validation of a Method of Screening for Sleep Disorders in Children With Cerebral Palsy, Using Connected Tools

Validation of a Simple Method of Screening for Sleep Disorders in Children With Cerebral Palsy, Using Connected Tools

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT03915418
Acronym
SOUTIEN-PC
Enrollment
140
Registered
2019-04-16
Start date
2021-01-12
Completion date
2027-02-01
Last updated
2026-06-25

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Sleep Disorders

Keywords

Screening, sleep disorders, children, cerebral palsy, connected tools

Brief summary

Cerebral palsy (CP) is the most common cause of child disability. Nearly 40% of PC children suffer from sleep disorders, which are not routinely screened. The neuro-cognitive, physical and environmental morbidity of sleep disorders should require their diagnosis and management. Limited access to the reference exam (polysomnography or PSG) delays the diagnosis and only allows screening of these disorders for a limited number of PC children. The hypothesis of our study is that connected technologies could optimize screening for sleep disorders in PC children by selecting children requiring PSG exploration and specific management.

Interventions

At home, parents will record their child's sleep for 1night Then, on the date scheduled for the inclusion of the children and after the recording of the 1 night at home, the child will spend a night in a hospital environment to carry out the recording by polysomnography and tools connected simultaneously.

Sponsors

University Hospital, Brest
Lead SponsorOTHER

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
DIAGNOSTIC
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
6 Years to 15 Years
Healthy volunteers
No

Inclusion criteria

* Boy or girl between 6 and 15 years old * Confirmed diagnosis of cerebral palsy * GMFCS class\> 3 * Parents and child agreement

Exclusion criteria

* Pharmacological treatment of sleep disorders * Diurnal and / or nocturnal ventilatory support * Difficulty understanding and / or participation * Subjects under 6 and over 15 * Refusal to participate * Not affiliated with and not a beneficiary of a health insurance plan

Design outcomes

Primary

MeasureTime frameDescription
Sensitivity of the diagnosis of sleep disorder15 daysSensitivity of sleep disorder diagnosis (positive / negative) obtained using connected tools in reference to that obtained by PSG
Specificity of the diagnosis of sleep disorder15 daysSpecificity of sleep disorder diagnosis (positive / negative) obtained using connected tools in reference to that obtained by PSG

Secondary

MeasureTime frameDescription
Diagnosis15 daysSensitivity and specificity of sleep disorder diagnosis using tools connected during 1 night at home (in comparaison with sleep disorder diagnosis using PSG)
Acceptability assessed by acceptability score for parents, and if possible children15 daysAcceptability assessed by the acceptability score for parents, and if possible children, obtained by the SUS "System Usability Scale" scale. This questionnaire consists of ten questions to collect the subjective point of view of the user on the systems used
Sleep Quality Questionnaire15 daysSleep quality questionnaire used as a screening tool for sleep disorders: use of the Sleep Disturbance Scale for Children. Sleep Disturbance Scale for Children (SDSC) is a screening tool for sleep disorders in children and adolescents with good psychometric properties. It is one of the most used sleep questionnaires in the clinic but also in clinical research. Since its creation, the SDSC has been translated into several languages and recently validated in French. The ranking is obtained from a 26-item questionnaire completed by the parents. This scale distinguishes 6 major groups of sleep disorders: disorders of the installation or maintenance of sleep, breathing disorders, waking disorders, sleep-wake transition disorders, excessive daytime sleepiness and hypersudation of sleep.
Data quality outcome measures25 monthsData quality will be assessed by establishing for each sensor the ratio (expressed in percent value) between the duration of the data effectively recorded to the total duration the patient weared the sensors. Pauses in recording during recording sessions will be identified in absolute value and duration for each sensor. Specific issues in recording will be reported, especially regarding the contents of RAW files.
A cost analysis of the sensor screening strategy will be compared to the PSG and the quality of life25 monthsA cost analysis of the sensor screening strategy will be compared to the PSG and the quality of life, measured as quality-adjusted life year QALY, will be simulated for one-year health conditions.

Countries

France

Contacts

CONTACTJuliette Ropars, MD
juliette.ropars@chu-brest.fr02 98 22 33 89
PRINCIPAL_INVESTIGATORJuliette Ropars, MD

Brest University Hospital in France

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Jun 26, 2026